Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT. (Q46913215)

26 December 2017

title

Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT. (English)

1 reference

26 December 2017

1 reference

Rosemary Foster

1

1 reference

26 December 2017

Steven Solano

2

1 reference

26 December 2017

Jennifer Mahoney

3

1 reference

26 December 2017

Arlan Fuller

4

1 reference

26 December 2017

Esther Oliva

5

1 reference

26 December 2017

Michael V Seiden

6

1 reference

26 December 2017

language of work or name

English

0 references

publication date

24 January 2006

1 reference

26 December 2017

published in

Gynecologic Oncology

1 reference

26 December 2017

volume

101

1 reference

26 December 2017

issue

2

1 reference

26 December 2017

page(s)

363-366

1 reference

26 December 2017

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Biology of gastrointestinal stromal tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gastrointestinal stromal tumor presenting as a scrotal mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Malignant extragastrointestinal stromal tumor of bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

A gastrointestinal stromal tumor (GIST) masquerading as an ovarian mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gastrointestinal stromal tumor presenting as a pelvic mass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gastrointestinal stromal tumour of the pharynx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gastrointestinal stromal tumor: report of two unusual cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gastrointestinal stromal tumor arising in the rectovaginal septum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Gastrointestinal stromal tumors metastatic to the ovary: a report of five cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

C-kit expression in uterine leiomyosarcomas: an immunocytochemical study of 29 cases of malignant smooth muscle tumors of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.12.022

10.1016/J.YGYNO.2005.12.022

7 January 2021

Identifiers

DOI

1 reference

26 December 2017

release_rxesrj7iz5gezmfom3nnw7ucyi

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rxesrj7iz5gezmfom3nnw7ucyi

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16439005

1 reference

26 December 2017